US Stock MarketDetailed Quotes

AUTL Autolus Therapeutics

Watchlist

3.990
+0.030+0.76%

Close Aug 23 16:00 ET

3.990
0.0000.00%

Post 19:47 ET

1.06BMarket Cap-3500P/E (TTM)

Autolus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-33.91%-51.08M

4.49%-40.51M

-29.63%-145.59M

-70.49%-24.83M

-25.97%-40.19M

-23.82%-38.15M

-21.09%-42.42M

4.71%-112.31M

-59.05%-14.57M

8.19%-31.9M

Net income from continuing operations

-27.92%-58.27M

-32.35%-52.69M

-40.01%-208.38M

-186.34%-77.17M

-7.20%-45.85M

-8.31%-45.55M

-7.42%-39.81M

-4.75%-148.84M

35.32%-26.95M

-25.83%-42.77M

Operating gains losses

83.73%-533K

108.33%1.68M

-184.53%-3.81M

-20.46%-7.26M

11.73%5.92M

---3.28M

--804K

571.28%4.51M

---6.03M

--5.3M

Depreciation and amortization

25.33%1.9M

-4.90%1.81M

-11.55%6.57M

7.64%1.78M

-22.83%1.38M

-21.21%1.51M

-8.13%1.9M

-12.25%7.42M

-21.63%1.65M

-27.00%1.79M

Deferred tax

185.06%74K

-18.97%-232K

-267.91%-986K

-246.08%-466K

-48.75%-238K

65.61%-87K

-12.07%-195K

-272.22%-268K

175.95%319K

-168.67%-160K

Other non cash items

91.04%11.32M

244.06%20.4M

299.09%49.15M

396.14%34.18M

70.62%3.12M

227.58%5.93M

231.17%5.93M

154.99%12.32M

42.98%6.89M

182,700.00%1.83M

Change In working capital

-1,434.88%-8.92M

-2.24%-13.75M

-45.52%292K

239.37%20.83M

-533.82%-7.76M

272.16%668K

-237.06%-13.45M

30.73%536K

-66.23%6.14M

75.24%-1.22M

-Change in prepaid assets

-254.40%-6.67M

-150.19%-10.11M

223.62%13.36M

86.92%18.14M

52.56%-5.06M

194.03%4.32M

23.01%-4.04M

-262.45%-10.81M

-65.62%9.71M

18.63%-10.67M

-Change in payables and accrued expense

-182.09%-834K

66.24%-2.46M

-96.95%489K

1,019.47%7.24M

-105.08%-487K

-75.72%1.02M

-550.12%-7.28M

517.75%16.03M

110.90%647K

25.29%9.58M

-Change in other current liabilities

69.65%-1.42M

44.36%-1.18M

-189.20%-13.56M

----

---4.67M

---2.13M

-94.89%-4.69M

----

-Change in other working capital

----

---132K

Cash from discontinued investing activities

Operating cash flow

-33.91%-51.08M

4.49%-40.51M

-29.63%-145.59M

-70.49%-24.83M

-25.97%-40.19M

-23.82%-38.15M

-21.09%-42.42M

4.71%-112.31M

-59.05%-14.57M

8.19%-31.9M

Investing cash flow

Cash flow from continuing investing activities

80.84%-841K

85.28%-533K

-1.34%-10.99M

-133.33%-1.48M

77.96%-1.5M

-66.25%-4.39M

-369.78%-3.62M

-22.40%-10.84M

60.06%-633K

-76.04%-6.8M

Net PPE purchase and sale

80.84%-841K

85.28%-533K

-1.34%-10.99M

-133.33%-1.48M

77.96%-1.5M

-66.25%-4.39M

-369.78%-3.62M

-22.40%-10.84M

60.06%-633K

-76.04%-6.8M

Cash from discontinued investing activities

Investing cash flow

80.84%-841K

85.28%-533K

-1.34%-10.99M

-133.33%-1.48M

77.96%-1.5M

-66.25%-4.39M

-369.78%-3.62M

-22.40%-10.84M

60.06%-633K

-76.04%-6.8M

Financing cash flow

Cash flow from continuing financing activities

-849.32%-2.08M

81,350.51%561.44M

-100.39%-883K

-99.99%23K

-96.08%4K

-219K

-69,000.00%-691K

-21.28%223.61M

51.62%223.51M

144.35%102K

Net common stock issuance

--0

--549.98M

--0

----

--0

-33.37%163.85M

----

Proceeds from stock option exercised by employees

--125K

--285K

-76.92%27K

--23K

--4K

--0

-6.40%117K

--0

----

Net other financing activities

-906.39%-2.2M

1,717.80%11.18M

-101.53%-910K

--0

---219K

-69,000.00%-691K

56.79%59.64M

--59.66M

---15K

Cash from discontinued financing activities

Financing cash flow

-849.32%-2.08M

81,350.51%561.44M

-100.39%-883K

-99.99%23K

-96.08%4K

---219K

-69,000.00%-691K

-21.28%223.61M

51.62%223.51M

144.35%102K

Net cash flow

Beginning cash position

121.21%759.54M

-37.21%240.34M

23.20%382.76M

57.22%256.85M

42.01%307.83M

27.69%343.36M

23.20%382.76M

101.63%310.68M

-5.71%163.37M

0.09%216.76M

Current changes in cash

-26.31%-54M

1,213.57%520.39M

-256.73%-157.46M

-112.62%-26.29M

-7.99%-41.68M

-27.83%-42.76M

-30.53%-46.73M

-36.15%100.46M

52.42%208.31M

0.62%-38.6M

Effect of exchange rate changes

-80.39%1.42M

-116.18%-1.19M

152.97%15.03M

-11.82%9.77M

37.13%-9.3M

138.71%7.23M

222.47%7.33M

-3,663.40%-28.38M

1,409.95%11.08M

-232.32%-14.8M

End cash Position

129.66%706.96M

121.21%759.54M

-37.21%240.34M

57.22%256.85M

42.01%307.83M

27.69%343.36M

23.20%382.76M

-5.71%163.37M

Free cash flow

-22.07%-51.92M

10.85%-41.05M

-27.14%-156.57M

-73.10%-26.31M

-7.71%-41.69M

-27.17%-42.54M

-28.60%-46.04M

2.82%-123.15M

-41.48%-15.2M

-0.24%-38.7M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-33.91%-51.08M	4.49%-40.51M	-29.63%-145.59M	-70.49%-24.83M	-25.97%-40.19M	-23.82%-38.15M	-21.09%-42.42M	4.71%-112.31M	-59.05%-14.57M	8.19%-31.9M
Net income from continuing operations	-27.92%-58.27M	-32.35%-52.69M	-40.01%-208.38M	-186.34%-77.17M	-7.20%-45.85M	-8.31%-45.55M	-7.42%-39.81M	-4.75%-148.84M	35.32%-26.95M	-25.83%-42.77M
Operating gains losses	83.73%-533K	108.33%1.68M	-184.53%-3.81M	-20.46%-7.26M	11.73%5.92M	---3.28M	--804K	571.28%4.51M	---6.03M	--5.3M
Depreciation and amortization	25.33%1.9M	-4.90%1.81M	-11.55%6.57M	7.64%1.78M	-22.83%1.38M	-21.21%1.51M	-8.13%1.9M	-12.25%7.42M	-21.63%1.65M	-27.00%1.79M
Deferred tax	185.06%74K	-18.97%-232K	-267.91%-986K	-246.08%-466K	-48.75%-238K	65.61%-87K	-12.07%-195K	-272.22%-268K	175.95%319K	-168.67%-160K
Other non cash items	91.04%11.32M	244.06%20.4M	299.09%49.15M	396.14%34.18M	70.62%3.12M	227.58%5.93M	231.17%5.93M	154.99%12.32M	42.98%6.89M	182,700.00%1.83M
Change In working capital	-1,434.88%-8.92M	-2.24%-13.75M	-45.52%292K	239.37%20.83M	-533.82%-7.76M	272.16%668K	-237.06%-13.45M	30.73%536K	-66.23%6.14M	75.24%-1.22M
-Change in prepaid assets	-254.40%-6.67M	-150.19%-10.11M	223.62%13.36M	86.92%18.14M	52.56%-5.06M	194.03%4.32M	23.01%-4.04M	-262.45%-10.81M	-65.62%9.71M	18.63%-10.67M
-Change in payables and accrued expense	-182.09%-834K	66.24%-2.46M	-96.95%489K	1,019.47%7.24M	-105.08%-487K	-75.72%1.02M	-550.12%-7.28M	517.75%16.03M	110.90%647K	25.29%9.58M
-Change in other current liabilities	69.65%-1.42M	44.36%-1.18M	-189.20%-13.56M	----	----	---4.67M	---2.13M	-94.89%-4.69M	----	----
-Change in other working capital	----	----	----	----	----	----	----	----	----	---132K
Cash from discontinued investing activities
Operating cash flow	-33.91%-51.08M	4.49%-40.51M	-29.63%-145.59M	-70.49%-24.83M	-25.97%-40.19M	-23.82%-38.15M	-21.09%-42.42M	4.71%-112.31M	-59.05%-14.57M	8.19%-31.9M
Investing cash flow
Cash flow from continuing investing activities	80.84%-841K	85.28%-533K	-1.34%-10.99M	-133.33%-1.48M	77.96%-1.5M	-66.25%-4.39M	-369.78%-3.62M	-22.40%-10.84M	60.06%-633K	-76.04%-6.8M
Net PPE purchase and sale	80.84%-841K	85.28%-533K	-1.34%-10.99M	-133.33%-1.48M	77.96%-1.5M	-66.25%-4.39M	-369.78%-3.62M	-22.40%-10.84M	60.06%-633K	-76.04%-6.8M
Cash from discontinued investing activities
Investing cash flow	80.84%-841K	85.28%-533K	-1.34%-10.99M	-133.33%-1.48M	77.96%-1.5M	-66.25%-4.39M	-369.78%-3.62M	-22.40%-10.84M	60.06%-633K	-76.04%-6.8M
Financing cash flow
Cash flow from continuing financing activities	-849.32%-2.08M	81,350.51%561.44M	-100.39%-883K	-99.99%23K	-96.08%4K	-219K	-69,000.00%-691K	-21.28%223.61M	51.62%223.51M	144.35%102K
Net common stock issuance	--0	--549.98M	--0	----	----	--0	--0	-33.37%163.85M	----	----
Proceeds from stock option exercised by employees	--125K	--285K	-76.92%27K	--23K	--4K	--0	--0	-6.40%117K	--0	----
Net other financing activities	-906.39%-2.2M	1,717.80%11.18M	-101.53%-910K	--0	--0	---219K	-69,000.00%-691K	56.79%59.64M	--59.66M	---15K
Cash from discontinued financing activities
Financing cash flow	-849.32%-2.08M	81,350.51%561.44M	-100.39%-883K	-99.99%23K	-96.08%4K	---219K	-69,000.00%-691K	-21.28%223.61M	51.62%223.51M	144.35%102K
Net cash flow
Beginning cash position	121.21%759.54M	-37.21%240.34M	23.20%382.76M	57.22%256.85M	42.01%307.83M	27.69%343.36M	23.20%382.76M	101.63%310.68M	-5.71%163.37M	0.09%216.76M
Current changes in cash	-26.31%-54M	1,213.57%520.39M	-256.73%-157.46M	-112.62%-26.29M	-7.99%-41.68M	-27.83%-42.76M	-30.53%-46.73M	-36.15%100.46M	52.42%208.31M	0.62%-38.6M
Effect of exchange rate changes	-80.39%1.42M	-116.18%-1.19M	152.97%15.03M	-11.82%9.77M	37.13%-9.3M	138.71%7.23M	222.47%7.33M	-3,663.40%-28.38M	1,409.95%11.08M	-232.32%-14.8M
End cash Position	129.66%706.96M	121.21%759.54M	-37.21%240.34M	-37.21%240.34M	57.22%256.85M	42.01%307.83M	27.69%343.36M	23.20%382.76M	23.20%382.76M	-5.71%163.37M
Free cash flow	-22.07%-51.92M	10.85%-41.05M	-27.14%-156.57M	-73.10%-26.31M	-7.71%-41.69M	-27.17%-42.54M	-28.60%-46.04M	2.82%-123.15M	-41.48%-15.2M	-0.24%-38.7M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall